Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SeegnalFRA:2I1 -0.28%2 Dividend Yield % is 0.00% as of Aug. 04, 2026. GuruFocus rates FRA:2I1 with a GF Score™ of 2/100. The stock has 3 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Seegnal ranks worse than 362318.48% on this metric.
As of today (2026-08-04), the Trailing Annual Dividend Yield of Seegnal is 0.00%.
The historical rank and industry rank for Seegnal's Dividend Yield % or its related term are showing as below:
FRA:2I1's Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.355 * Ranked among companies with meaningful Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Seegnal's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2I1 vs VEEV, BTSG, HQY: Dividend Yield % Comparison
For the Health Information Services subindustry, Seegnal's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seegnal Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Seegnal's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Seegnal's Dividend Yield % falls into.
Seegnal (FRA:2I1) has a Dividend Yield % of 0.00% as of Aug. 04, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Seegnal and its competitors. According to the industry distribution chart, Seegnal ranks #999999 out of 276 companies in the Healthcare Providers & Services industry.
Is Seegnal's Dividend Yield % too high?
Seegnal's current Dividend Yield % is 0.00%. Based on the distribution chart, Seegnal ranks #999999 out of 276 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Seegnal has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Seegnal's Dividend Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Seegnal ranks #999999 out of 276 companies for Dividend Yield %. This places Seegnal in the lower half of its industry. The industry median Dividend Yield % is 2.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.36, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Seegnal and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seegnal's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seegnal stock overvalued right now?
Seegnal (FRA:2I1) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Seegnal's overall GF Score™ is 2/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Seegnal (FRA:2I1), the current Dividend Yield % is 0.00% as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Seegnal Inc is a med-tech software as a service (SaaS) company focused on the development and commercialization of a patient-centric clinical decision support system designed to mitigate drug-related problems at the point of care. It provides AI-enhanced clinical decision support software that helps healthcare providers prescribe medications safely and efficiently at the point of care (the Seegnal Platform). It analyzes patient-specific clinical data and medication regimens in real time to identify potential drug-related risks, including drug-drug interactions, contraindications, and adverse drug events. By integrating with electronic medical record systems, its platform supports clinicians in improving patient safety, optimizing medication use, and reducing healthcare costs.
2GF Score
Get the complete analysis for FRA:2I1
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2I1 has been successfully added to your 
